Icon
+91 94997 68112
Login Register

Afinitor Disperz - (2,3,5 mg; Tablet For Suspension)

Everolimus Novartis
2,3,5 mg; Tablet For Suspension
More Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None
Less Than 5
Used to treat adults and children with a genetic condition called tuberous sclerosis complex (TSC) who have a brain tumor called subependymal giant cell astrocytoma (SEGA)
Yes
***** ***** ** ** *** **** ** ****** **** ******** ** *** ****. ***** *** ********* **** ** **** ******* (*** *, ****), *******(*** **, ****) *** ******* (*** **, ****) ** ******* *** ** ********* ** ********. ***** **** *** ***** ************ ******* ******* *** *** *** ******* ** **** *** ***** ****** ****** *** ******* ******* ***-********** *****. ***** *** ** **** *** ******* ** ******** ** *******.
Afinitor Disperz Patent 1 Patent 2 Patent 3 Patent 4
***** ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** *, **** ******* ******** ************ ******** ** *** **, ****
  1. *** **, **** : ***** ******** ******** ********* **** ** ******* ******* (*** *, ****), *******(*** **, ****) *** ******* (*** **, ****) ** *******.
  2. *** *, **** : ******** **** ***** ** ** ** ******** *** ******** ******** ** **** ********.
  3. *** **, **** : ***** **** *** ******* *******.
  4. *** **, **** : ********** **** ***** *********.
  5. *** *, **** : ***** ******** *** *******.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.